$WAT

Waters Corporation Raises 2026 Guidance as Q3 Revenue Surges 121% to $1.77 Billion

Waters Corporation (WAT) reported Q3 revenue of $1.77B, up 121% YoY, beating estimates. Adjusted EPS was $4.10, exceeding expectations. The company raised 2026 guidance, now forecasting EPS of $14.60-$14.70 and revenue of $6.48B-$6.50B. It also acquired MOBILion Systems for advanced molecular analysis technology.

Original reporting
Published Nov 3, 2026, 1:34 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 2:11 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Waters Corporation Raises 2026 Guidance as Q3 Revenue Surges 121% to $1.77 Billion — source image
Decision brief

The 30-second read

$WATBullishHigh
01

Why it matters

The combination of a Q3 beat, raised 2026 EPS and revenue guidance, and an acquisition of MOBILion Systems provides multiple expectation-setting catalysts for traders.

02

Market read

Guidance raise with specific EPS and revenue ranges plus a technology acquisition is likely to drive near-term positioning and revisions across the lab-instruments complex.

03

What to watch

Acquisition financial terms are undisclosed, leaving uncertainty around deal economics, integration costs, and how quickly MOBILion technology translates into revenue.

Relevance 9/10Novelty 9/10Timing: premarket after Q3 results, guidance raise, and acquisition announcement

Background

Waters operates Analytical Sciences and Biosciences divisions, with growth supported by instruments and recurring consumables/reagents.

Company-level read

Ticker impact

$WATBullishHigh confidence
Context

Waters reported Q3 EPS of $4.10 and revenue of $1.77B, then raised full-year 2026 guidance and announced the MOBILion Systems acquisition.

Expected impact

Likely upward bias as the market prices in stronger 2026 earnings and growth visibility, tempered by uncertainty around acquisition economics and Q4 profitability.

Evidence & confidence

The article discloses a fresh guidance raise with specific EPS and revenue ranges, alongside a disclosed acquisition of a technology specialist; both are direct drivers for valuation and expectations.

Market effects

Signals continued demand strength in analytical instruments and recurring consumables, potentially supportive for life-science tools sentiment.

Primarily US-listed large-cap biotech/lab-instrument sentiment; limited direct regional spillover described.

Acquisition expands high-resolution molecular analysis capabilities, relevant to global pharma and life-science research tooling demand.

Counterpoint

Q4 EPS midpoint is slightly below consensus, so the market may focus on profitability trajectory rather than revenue momentum.

Key entities

  • Waters Corporation

    Reported Q3 results, raised full-year 2026 guidance, and announced acquisition of MOBILion Systems.

  • MOBILion Systems

    Specialist in high-resolution ion mobility separation technology to expand Waters' analytical portfolio.

  • Udit Batra

    Waters CEO who attributed growth to consumables, product innovation, and higher customer testing volumes.

Related articles

$WATHighAI 8/10

Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results

WATERS CORP /DE/ (WAT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 For Immediate Release Contact: Caspar Tudor, Head of Investor Relations – (508) 482-3448 Waters Corporation (NYSE: WAT) Reports Third Quarter 2026 Financial Results Company to Provide Starting 2027 Growth Framework on Earnings Conference Call Third Quarter 2026 Highl

$WATHighAI 8/10

Waters Corp. Q3 Adjusted EPS Rises 21%; Raises Annual Outlook; Stock Up

Waters Corp. (WAT) reported Q3 net income fell to $81M ($0.82 EPS) due to costs, but adjusted EPS rose 21% to $4.10. Revenue hit $1.767B, with organic growth of 9%. The company raised its 2026 outlook, expecting organic revenue growth of 9.1% to 9.7% and adjusted EPS of $14.60 to $14.70. Shares rose 6% in pre-market trading.

$WATMed

Waters Acquires MOBILion Systems To Expand Proteomics Business

Waters Corp. (WAT) acquired MOBILion Systems to expand its proteomics business. The deal combines MOBILion's SLIM tech with Waters' Xevo MRT platform, aiming to enhance protein research. The LC-MS proteomics market is valued at $2B with high single-digit annual growth. Financial terms were not disclosed.

$WATHighAI 8/10

Waters beats Q3 estimates, raises full-year guidance

Waters Corporation (NYSE:WAT) reported Q3 adjusted EPS of $4.10, beating estimates by $0.10, with revenue of $1.77B, up 121% YoY. The company raised full-year 2026 guidance, expecting adjusted EPS of $14.60-$14.70 and revenue of $6.48B-$6.50B. Q4 guidance was mixed. Organic revenue grew 9%, driven by strong divisional performance. The company also acquired MOBILion Systems, Inc.

$WATHighAI 8/10

Waters earnings beat by $0.10, revenue topped estimates

Waters (WAT) reported Q3 EPS of $4.10, beating estimates by $0.10, with revenue at $1.77B, exceeding expectations. The company provided Q4 and FY 2026 guidance, with EPS and revenue estimates generally in line with or slightly above consensus. WAT's stock is up 12.47% over the last 3 months and 22.37% over the last 12 months.